CBIO
CRESCENT BIOPHARMA, INC.
-0.30 (-1.78%)16.88USD188K成交股數627M市值–本益比(近四季)52.8股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 4 · 49.5M · 4 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 7 · 1.2M · 7 |
| 其中 10b5-1 計畫賣出 | 7 筆 |
| 近 180 天 買進 · 賣出金額 | 49.5M · 1.2M |
| 近 180 天 淨額 | 48.3M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-16 | 07-20 | Harwin Peter Evan | Director,TenPercentOwner | P 公開市場買進 | 853K | 14.50 | 12.4M | 3.6M | SEC |
| 2026-07-16 | 07-20 | Fairmount Funds Management LLC | Director,TenPercentOwner | P 公開市場買進 | 853K | 14.50 | 12.4M | 3.6M | SEC |
| 2026-07-16 | 07-20 | Kiselak Tomas | Director,TenPercentOwner | P 公開市場買進 | 853K | 14.50 | 12.4M | 3.6M | SEC |
| 2026-07-16 | 07-20 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | P 公開市場買進 | 853K | 14.50 | 12.4M | 3.6M | SEC |
| 2026-06-22 | 06-23 | McNeill Jonathan | President and COO | S 公開市場賣出(10b5-1) | 20.5K | 17.99 | 370K | 139K | SEC |
| 2026-06-22 | 06-23 | Bispham Barbara Harlin | See Remarks | S 公開市場賣出(10b5-1) | 1.2K | 17.99 | 22K | 19.3K | SEC |
| 2026-06-22 | 06-23 | Brumm Joshua T | Chief Executive Officer | S 公開市場賣出(10b5-1) | 42.3K | 17.99 | 761K | 281K | SEC |
| 2026-06-22 | 06-23 | Pinkas Jan | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.3K | 17.99 | 23K | 22.2K | SEC |
| 2026-06-22 | 06-23 | Im Ellie Eunkyung | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.2K | 17.99 | 22K | 22.1K | SEC |
| 2026-06-22 | 06-23 | Scalzo Richard William | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.1K | 17.99 | 20K | 20.3K | SEC |
| 2026-06-22 | 06-23 | Lynch Ryan | See Remarks | S 公開市場賣出(10b5-1) | 465 | 17.99 | 8K | 13.9K | SEC |
| 2025-12-15 | 12-17 | Lynch Ryan | See Remarks | A 獲配股票 | 4.0K | – | – | 12.4K | SEC |
| 2025-12-15 | 12-17 | McNeill Jonathan | President and COO | A 獲配股票 | 6.0K | – | – | 160K | SEC |
| 2025-12-15 | 12-17 | Pinkas Jan | Chief Scientific Officer | A 獲配股票 | 5.0K | – | – | 22.5K | SEC |
| 2025-12-15 | 12-17 | Scalzo Richard William | Chief Financial Officer | A 獲配股票 | 5.0K | – | – | 19.4K | SEC |
| 2025-12-15 | 12-17 | Doughty Christopher Grant | Chief Business Officer | A 獲配股票 | 14.7K | – | – | 54.2K | SEC |
| 2025-12-15 | 12-17 | Brumm Joshua T | Chief Executive Officer | A 獲配股票 | 45.1K | – | – | 314K | SEC |
| 2025-12-15 | 12-17 | Pinkas Jan | Chief Scientific Officer | A 獲配股票 | 17.5K | – | – | 17.5K | SEC |
| 2025-12-15 | 12-17 | Scalzo Richard William | Chief Financial Officer | A 獲配股票 | 14.4K | – | – | 14.4K | SEC |
| 2025-12-15 | 12-17 | McNeill Jonathan | President and COO | A 獲配股票 | 19.5K | – | – | 154K | SEC |
| 2025-12-15 | 12-17 | Lynch Ryan | See Remarks | A 獲配股票 | 8.4K | – | – | 8.4K | SEC |
| 2025-12-15 | 12-17 | Doughty Christopher Grant | Chief Business Officer | A 獲配股票 | 8.0K | – | – | 62.2K | SEC |
| 2025-12-15 | 12-17 | Im Ellie Eunkyung | Chief Medical Officer | A 獲配股票 | 16.3K | – | – | 16.3K | SEC |
| 2025-12-15 | 12-17 | Bispham Barbara Harlin | See Remarks | A 獲配股票 | 6.0K | – | – | 18.4K | SEC |
| 2025-12-15 | 12-17 | Bispham Barbara Harlin | See Remarks | A 獲配股票 | 12.4K | – | – | 12.4K | SEC |
| 2025-12-15 | 12-17 | Brumm Joshua T | Chief Executive Officer | A 獲配股票 | 10.0K | – | – | 324K | SEC |
| 2025-12-15 | 12-17 | Im Ellie Eunkyung | Chief Medical Officer | A 獲配股票 | 5.0K | – | – | 21.3K | SEC |
| 2025-12-04 | 12-08 | Fairmount Funds Management LLC | Director,TenPercentOwner | P 公開市場買進 | 1.4M | 13.41 | 18.2M | 2.7M | SEC |
| 2025-12-04 | 12-08 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | P 公開市場買進 | 1.4M | 13.41 | 18.2M | 2.7M | SEC |
| 2025-12-04 | 12-08 | Harwin Peter Evan | Director,TenPercentOwner | P 公開市場買進 | 1.4M | 13.41 | 18.2M | 2.7M | SEC |
| 2025-12-04 | 12-08 | Kiselak Tomas | Director,TenPercentOwner | P 公開市場買進 | 1.4M | 13.41 | 18.2M | 2.7M | SEC |
| 2025-06-13 | 06-17 | BVF II GP LLC | Other | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BVF GP HOLDINGS LLC | TenPercentOwner | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | Biotechnology Value Trading Fund OS LP | Other | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BVF II GP LLC | Other | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | BVF II GP LLC | Other | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BIOTECHNOLOGY VALUE FUND L P | TenPercentOwner | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BVF I GP LLC | TenPercentOwner | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BVF I GP LLC | TenPercentOwner | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BVF Partners OS Ltd. | Other | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | BVF Partners OS Ltd. | Other | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BVF Partners OS Ltd. | Other | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | Biotechnology Value Trading Fund OS LP | Other | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | BVF GP HOLDINGS LLC | TenPercentOwner | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | Biotechnology Value Trading Fund OS LP | Other | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | LAMPERT MARK N | TenPercentOwner | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | LAMPERT MARK N | TenPercentOwner | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | LAMPERT MARK N | TenPercentOwner | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BIOTECHNOLOGY VALUE FUND II LP | Other | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | BIOTECHNOLOGY VALUE FUND II LP | Other | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BIOTECHNOLOGY VALUE FUND II LP | Other | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BVF INC/IL | TenPercentOwner | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | BVF INC/IL | TenPercentOwner | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BVF I GP LLC | TenPercentOwner | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | BVF INC/IL | TenPercentOwner | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BVF PARTNERS L P/IL | TenPercentOwner | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BIOTECHNOLOGY VALUE FUND L P | TenPercentOwner | J 其他 | 557K | – | – | 594K | SEC |
| 2025-06-13 | 06-17 | BVF GP HOLDINGS LLC | TenPercentOwner | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BVF PARTNERS L P/IL | TenPercentOwner | J 其他 | 657K | – | – | 707K | SEC |
| 2025-06-13 | 06-17 | BVF PARTNERS L P/IL | TenPercentOwner | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2025-06-13 | 06-17 | BIOTECHNOLOGY VALUE FUND L P | TenPercentOwner | J 其他 | 56.1K | – | – | 62.4K | SEC |
| 2024-08-08 | 08-09 | DEBBANE RAYMOND | TenPercentOwner | S 公開市場賣出 | 261K | 0.19 | 50K | 6.3M | SEC |
| 2024-08-08 | 08-09 | Invus Global Management, LLC | TenPercentOwner | S 公開市場賣出 | 261K | 0.19 | 50K | 6.3M | SEC |
| 2024-08-08 | 08-09 | Invus Public Equities Advisors, LLC | TenPercentOwner | S 公開市場賣出 | 261K | 0.19 | 50K | 6.3M | SEC |
| 2024-08-08 | 08-09 | Siren, L.L.C. | TenPercentOwner | S 公開市場賣出 | 261K | 0.19 | 50K | 6.3M | SEC |
| 2024-08-08 | 08-09 | Invus Public Equities, L.P. | TenPercentOwner | S 公開市場賣出 | 261K | 0.19 | 50K | 6.3M | SEC |
| 2024-08-07 | 08-09 | Invus Public Equities, L.P. | TenPercentOwner | S 公開市場賣出 | 61.5K | 0.18 | 11K | 6.6M | SEC |
| 2024-08-07 | 08-09 | Invus Public Equities Advisors, LLC | TenPercentOwner | S 公開市場賣出 | 61.5K | 0.18 | 11K | 6.6M | SEC |
| 2024-08-07 | 08-09 | DEBBANE RAYMOND | TenPercentOwner | S 公開市場賣出 | 61.5K | 0.18 | 11K | 6.6M | SEC |
| 2024-08-07 | 08-09 | Invus Global Management, LLC | TenPercentOwner | S 公開市場賣出 | 61.5K | 0.18 | 11K | 6.6M | SEC |
| 2024-08-07 | 08-09 | Siren, L.L.C. | TenPercentOwner | S 公開市場賣出 | 61.5K | 0.18 | 11K | 6.6M | SEC |
| 2024-08-06 | 08-07 | Siren, L.L.C. | TenPercentOwner | S 公開市場賣出 | 55.7K | 0.18 | 10K | 6.6M | SEC |
| 2024-08-06 | 08-07 | Invus Public Equities Advisors, LLC | TenPercentOwner | S 公開市場賣出 | 55.7K | 0.18 | 10K | 6.6M | SEC |
| 2024-08-06 | 08-07 | Invus Public Equities, L.P. | TenPercentOwner | S 公開市場賣出 | 55.7K | 0.18 | 10K | 6.6M | SEC |
| 2024-08-06 | 08-07 | DEBBANE RAYMOND | TenPercentOwner | S 公開市場賣出 | 55.7K | 0.18 | 10K | 6.6M | SEC |
| 2024-08-06 | 08-07 | Invus Global Management, LLC | TenPercentOwner | S 公開市場賣出 | 55.7K | 0.18 | 10K | 6.6M | SEC |
| 2024-08-05 | 08-07 | Invus Global Management, LLC | TenPercentOwner | S 公開市場賣出 | 165K | 0.19 | 31K | 6.7M | SEC |
| 2024-08-05 | 08-07 | Siren, L.L.C. | TenPercentOwner | S 公開市場賣出 | 165K | 0.19 | 31K | 6.7M | SEC |
| 2024-08-05 | 08-07 | Invus Public Equities, L.P. | TenPercentOwner | S 公開市場賣出 | 165K | 0.19 | 31K | 6.7M | SEC |
| 2024-08-05 | 08-07 | Invus Public Equities Advisors, LLC | TenPercentOwner | S 公開市場賣出 | 165K | 0.19 | 31K | 6.7M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 4.1M | 74.4M | 新進 | 新進 |
| BVF INC/IL | 2.7M | 49.5M | 新進 | 新進 |
| Fairmount Funds Management LLC | 2.7M | 49.5M | 新進 | 新進 |
| Venrock Adviser, LLC | 2.1M | 38.4M | 新進 | 新進 |
| Logos Global Management LP | 1.9M | 34.2M | 新進 | 新進 |
| FCPM III SERVICES B.V. | 1.7M | 30.2M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 1.7M | 29.9M | 新進 | 新進 |
| Vestal Point Capital, LP | 1.6M | 29.3M | 新進 | 新進 |
| Opaleye Management Inc. | 1.3M | 23.7M | 新進 | 新進 |
| BlackRock, Inc. | 1.3M | 22.9M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 1.2M | 20.9M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 768K | 13.8M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 404K | 7.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 385K | 6.9M | 新進 | 新進 |
| JENNISON ASSOCIATES LLC | 379K | 6.8M | 新進 | 新進 |
| NEXTBio Capital Management LP | 373K | 6.7M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 373K | 6.7M | 新進 | 新進 |
| Remedium Capital Partners, LLC | 361K | 6.5M | 新進 | 新進 |
| STATE STREET CORP | 316K | 5.7M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 303K | 5.4M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 300K | 5.4M | 新進 | 新進 |
| MARSHALL WACE, LLP | 214K | 3.9M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 207K | 3.7M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 189K | 3.4M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 187K | 3.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 80 +20 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 80 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 29.1M · 78.4% |
| 合計季末市值 | 519M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.2M |
|---|---|
| 與上期比 | -1.4% |
| 佔流通股數 | 8.54% |
| 日均成交量 | 159K |
| 回補天數 | 19.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.2M | -1.4% | 8.54% | 159K | 19.9 |
| 2026-08-14 | 3.2M | -7.2% | 8.66% | 188K | 17.1 |
| 2026-07-31 | 3.5M | -7.4% | 9.33% | 388K | 8.9 |
| 2026-07-15 | 3.7M | +1.9% | 10.08% | 385K | 9.7 |
| 2026-06-30 | 3.7M | +9.8% | 9.89% | 523K | 7.0 |
| 2026-06-15 | 3.3M | +2.7% | 9.01% | 212K | 15.8 |
| 2026-05-29 | 3.3M | +12.3% | 8.77% | 289K | 11.3 |
| 2026-05-15 | 2.9M | +21.1% | 7.81% | 344K | 8.4 |
| 2026-04-30 | 2.4M | +7.5% | 6.45% | 270K | 8.9 |
| 2026-04-15 | 2.2M | -0.5% | 6.00% | 255K | 8.7 |
| 2026-03-31 | 2.2M | +54.6% | 6.03% | 247K | 9.1 |
| 2026-03-13 | 1.4M | +0.1% | 3.90% | 149K | 9.7 |
| 2026-02-27 | 1.4M | +14.2% | 3.89% | 164K | 8.8 |
| 2026-02-13 | 1.3M | +13.7% | 3.41% | 252K | 5.0 |
| 2026-01-30 | 1.1M | +24.2% | 3.00% | 205K | 5.4 |
| 2026-01-15 | 897K | +12.8% | 2.41% | 116K | 7.7 |
| 2025-12-31 | 795K | +0.1% | 2.14% | 92.2K | 8.6 |
| 2025-12-15 | 794K | +41.2% | 2.14% | 319K | 2.5 |
| 2025-11-28 | 563K | -3.1% | 1.51% | 48.4K | 11.6 |
| 2025-11-14 | 581K | +0.6% | 1.56% | 74.6K | 7.8 |
| 2025-10-31 | 578K | -0.9% | 1.55% | 103K | 5.6 |
| 2025-10-15 | 583K | +16.0% | 1.57% | 111K | 5.3 |
| 2025-09-30 | 502K | +91.8% | 1.35% | 151K | 3.3 |
| 2025-09-15 | 262K | +103.8% | 0.71% | 113K | 2.3 |
| 2025-08-29 | 129K | -9.0% | 0.35% | 104K | 1.2 |
| 2025-08-15 | 141K | +57.1% | 0.38% | 86.7K | 1.6 |